Brits on weight-loss injections warned over holiday mistake that could make medication unsafe

A UK pharmacist is warning that Brits travelling abroad while using GLP-1 weight-loss medicines could be putting their treatment at risk by making common mistakes with storage, flights and dosing. 

 

Hira Malik, superintendent pharmacist and co-founder of Oushk Pharmacy, said the run-up to summer holidays often raises practical questions for patients using weight-loss medication, with many unsure how to safely transport and store their medication while away. 

 

Hira said: “GLP-1 medicines can usually be managed safely while travelling, but they should not be treated like ordinary travel items. These are prescription medicines with specific storage, dosing and handling requirements. Elements like heat exposure, incorrect storage, missing paperwork or confusion around dosing can all affect whether treatment is used safely and correctly.” 

 

“Most holiday mistakes are definitely avoidable, but patients always need to understand how to stay safe before they travel”.  

 

To help keep Brits safe while travelling this summer, Hira has shared her top three GLP-1 holiday mistakes to watch out for: 

 

  1. Leaving pens in hot cars, beach bags or hotel rooms 

 

“Temperature control is one of the biggest things patients need to think about when travelling with GLP-1 medication. Pens should never be left in direct sunlight, in a parked car, by a pool, on a beach towel or close to a window. 

 

“Holiday environments can get much hotter than people realise, especially inside bags, cars and hotel rooms. If a medicine is exposed to temperatures outside its storage guidance, there may be a risk it is no longer suitable to use. 

 

“For Wegovy, unopened pens should still be stored in a refrigerator at 2°C to 8°C and must not be frozen. During use, the pen can be kept for up to six weeks either below 30°C or in the refrigerator. 

 

“Mounjaro KwikPen should also be refrigerated before use and must not be frozen, but once in use, it doesn’t need to be refrigerated. It can be kept for up to 30 days when stored in an environment above 30°C. 

 

“That flexibility can be helpful for travel, but it does not mean patients can ignore storage rules. If a pen has been left somewhere too hot, has frozen, looks damaged or the medicine looks unusual, patients should not use it without speaking to their pharmacist or prescriber.” 

 

  1. Packing weight-loss injections in hold luggage 

“A major mistake is putting GLP-1 medication into checked luggage,” Hira said. “Patients should usually keep prescribed weight-loss injections in their hand luggage, not their suitcase. 

 

“Hold luggage can be exposed to temperature changes and may be lost or delayed. If your medication is in your cabin bag, it is easier to keep it safe, accessible and protected during the journey. 

 

“Patients should also travel with the medicine in its original packaging, with the pharmacy label visible where possible, and carry proof that it has been prescribed to them. This could include a prescription copy, pharmacy documentation or a letter from their prescriber, depending on the destination and airline requirements. 

 

“Injectable medicines are common, but needles and sharps still need to be handled properly. Patients should check airline and destination guidance before travelling, rather than assuming the rules will be the same everywhere. 

 

 

  1. Changing dose plans because of holiday food, alcohol or timing 

“Another red flag is patients changing their dose plan because they are going away,” Hira said. “People may be tempted to skip a dose, delay treatment, double up later or move doses around to fit flights, meals or alcohol. 

 

“Patients should not adjust their GLP-1 dose or dosing schedule without clinical advice. Taking more medication to ‘make up’ for a missed dose can increase the risk of side effects. 

 

“Holiday routines can also make side effects harder to manage. Richer meals, alcohol, hot weather, lower fluid intake, disrupted sleep and changes in activity can all affect how someone feels on treatment. 

 

“Good GLP-1 care relies on planning and monitoring. If a patient is unsure how to manage treatment around travel, that conversation should happen before they leave.” 

 

“Patients should not feel rushed or uncertain before travelling,” Hira said. “Before going abroad, they should check how their specific medicine should be stored, what documentation they need to carry, and what to do if a dose is delayed or missed. 

 

“The safest approach is simple: keep the medicine traceable, protect it from heat and freezing, carry it with you, and do not change your treatment plan without clinical advice. GLP-1 medication can be managed safely on holiday, but it should be treated with the same care abroad as it would be at home.”